Cytokinetics, Incorporated · NASDAQ:CYTK

Henderson John T received 352 Cytokinetics, Incorporated shares as an award (Form 4)

Traded Oct 16, 2026 · Filed Oct 20, 2026

On Oct 16, 2026, Henderson John T (Director) received 352 Cytokinetics, Incorporated shares as an award at US$63.92 for US$22,500, leaving 78,712 shares. Filed Oct 20, 2026 (Form 4).

Awarded
352 shares
Price
US$63.92
Value
US$22,500
Holding after
78,712 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 16, 2026Common StockAward352US$63.9278,712Direct

Source

Download original · View original at SEC

Related